This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Seoul National University, The Asan Foundation, University of Ulsan Foundation for Industry Cooperation. Active years: 2016-2018.
Company Filing History:
1 out of 1,766 
1 out of 84 
1 out of 94 
Years Active: 2016-2018
Title: Sahmin Lee - Innovator in Medical Research
Introduction
Sahmin Lee is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medical research, particularly in the area of inflammatory diseases and vascular health. With a total of 2 patents, his work focuses on innovative methods and compositions that aim to improve health outcomes.
Latest Patents
One of his latest patents is titled "Human resistin receptor and use thereof." This invention concerns a human resistin receptor and provides methods for screening a receptor of human resistin protein. It also outlines a method for preventing or treating inflammatory diseases and arteriosclerosis using an expression- or activity-regulator for the human resistin receptor. This method enables the separation of a receptor that directly binds to resistin from human monocytes, revealing a mechanism of signal transduction. This research is expected to contribute to the regulation of inflammatory effects and the development of treatments for related diseases.
Another notable patent is "Composition for prophylaxis or treatment of vascular or cardiac valvular calcification comprising dipeptidyl peptidase-4 inhibitor." This composition includes a DPP-4 inhibitor, which is expressed at increased levels when blood vessels and valves are calcified. The administration of the DPP-4 inhibitor has shown remarkable decreases in calcification, making it a promising candidate for treatment or prevention of vascular or valvular calcification.
Career Highlights
Sahmin Lee has worked with esteemed institutions such as Seoul National University and The Asan Foundation. His research has been pivotal in advancing our understanding of inflammatory diseases and vascular health.
Collaborations
He has collaborated with notable colleagues, including Young Bae Park and Hyo Soo Kim, who have contributed to his research endeavors.
Conclusion
Sahmin Lee's innovative work in medical research, particularly through his patents, showcases his commitment to improving health outcomes. His contributions are expected to have a lasting impact on the treatment of inflammatory diseases and vascular conditions.